Original language | English |
---|---|
Pages (from-to) | 314-315 |
Number of pages | 2 |
Journal | World Psychiatry |
Volume | 21 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2022 |
Repurposing fluvoxamine, and other psychiatric medications, for COVID-19 and other conditions
Eric J. Lenze, Angela M. Reiersen, Paramala J. Santosh
- Washington University School of Medicine
- Department of Psychiatry
- Institute for Public Health
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Hope Center for Neurological Disorders
- COVID-19 Researchers
- Division of Child & Adolescent Psychiatry
- Intellectual and Developmental Disabilities Research Center (IDDRC)
Research output: Contribution to journal › Letter › peer-review
6
Scopus
citations